'For
the quarter ending March 2024, consolidated Net sales (including other operating income) of Divis Laboratories has increased 18.04% to Rs 2303 crore compared to quarter ended March 2023. Operating profit margin has jumped from 24.96% to 31.74%, leading to 50.10% rise in operating profit to Rs 731.00 crore. Raw material cost as a % of total sales (net of stock adjustments) decreased from 41.82% to 38.96%. Employee cost decreased from 13.35% to 12.89%. Other expenses fell from 19.62% to 16.18%. Other income rose 19.70% to Rs 79 crore. PBIDT rose 46.47% to Rs 810 crore. Provision for interest remained nil. Loan funds declined from Rs 4.00 crore as of 31 March 2023 to Rs 3.00 crore as of 31 March 2024. Inventories rose to Rs 3,184.00 crore as of 31 March 2024 from Rs 3,000.00 crore as of 31 March 2023. Sundry debtors were higher at Rs 2,156.00 crore as of 31 ...
Pleaselogin & subscribe to view the full report.
More Reports
-
(30-Aug-2024)
Gillette India
-
Net down 5% on lower sales
-
Net jump 159% on good operating show
-
Net up 50% on good operating show
|
|